MULTI-CANCER, MULTI-DISEASE, EARLY DETECTION TESTS USING A URINE SAMPLE
Please register and contact us if interested
1) To use our MinION enabled microRNA quantification services and solutions.
2) To participate remotely in a future IRB-approved study and provide your urine sample
for microRNA evaluation.
3) To collaborate in a grant application to implement and evaluate the Yenos microRNA
test in your facilities.
4) To use our consulting services in facilitating HPLC purity evaluation of your in-house
made mRNA batches.
Why is Early Detection Important?
All men are at risk for prostate cancer. Out of every 100 American men, about 13 will get prostate cancer during their lifetime, and about 2 to 3 men will die from it.
About 5-10% of pancreatic cancer patients survive past five years after diagnosis, and those with stage 4 pancreatic cancer have a five-year survival rate of 1%.
Screening mammograms miss about 1 in 8 breast cancers. After 10 yearly mammograms, the chance of having at least one false positive result is about 50%.